Search Results

The HDLC Precipitating Reagent is to be used in the separation of HDL from other serum lipoproteins to provide valuable information for the prediction of coronary heart disease when used in conjunction with total cholesterol and triglyceride determinations.

Not Found

This communication is an FDA 510(k) clearance letter for the HDLC Precipitating Reagent. It does not contain the detailed study information generally associated with acceptance criteria and device performance evaluation. The letter indicates that the device has been found substantially equivalent to a predicate device, which means its safety and effectiveness have been deemed comparable to a previously cleared device. However, the letter itself does not provide the specific data from the studies that supported this determination.

Therefore, most of the requested information cannot be extracted from this document alone. For a comprehensive answer, information from the original 510(k) submission (K982539) would be required.

Based only on the provided text, here's what can be inferred or stated as missing:

1. A table of acceptance criteria and the reported device performance

• Cannot be extracted. The document is a clearance letter, not a performance report. It states the device is "substantially equivalent" but does not detail the specific performance metrics or acceptance criteria used in the underlying studies.

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

• Cannot be extracted. This information is part of the original 510(k) submission, not the clearance letter.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

• Cannot be extracted. This information would be found in the detailed study protocol and results of the 510(k) submission.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

• Cannot be extracted. This information would typically be described in the study design section of the 510(k) submission.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

• Not applicable / Cannot be extracted. This is a reagent (HDLC Precipitating Reagent) used in a clinical laboratory setting, not an AI-assisted diagnostic imaging device. Therefore, MRMC studies and "human readers improve with AI" metrics are not relevant to this type of product.

6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done

• Not applicable / Cannot be extracted. This is a laboratory reagent. The concept of "standalone algorithm performance" without human-in-the-loop is not relevant here. The device's performance would be measured by its accuracy in separating HDL from other lipoproteins, which then informs a diagnostic interpretation by a clinician.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

• Cannot be extracted. For a precipitating reagent, the "ground truth" would likely involve comparison against established reference methods or highly accurate analytical techniques for lipoprotein separation and quantification. However, this detail is not in the clearance letter.

8. The sample size for the training set

• Not applicable / Cannot be extracted. A "training set" is typically associated with machine learning or AI models. This is a chemical reagent, so this concept does not apply in the same way. Performance studies would involve method validation, accuracy, precision, and interference studies.

9. How the ground truth for the training set was established

• Not applicable / Cannot be extracted. See explanation for #8.

Ask a specific question about this device

The Creatine kinase Reagent is to be used in the assessment of cardiac and skeletal muscle diseases, including myocardial infarction and muscle dystrophy.

Not Found

The provided text is a 510(k) clearance letter from the FDA for a Creatine Kinase Reagent. It states that the device has been found substantially equivalent to a predicate device for the assessment of cardiac and skeletal muscle diseases, including myocardial infarction and muscle dystrophy.

However, the document does not contain any information regarding acceptance criteria, reported device performance, sample sizes, expert qualifications, adjudication methods, or training set details. These are typical requirements for device validation studies, but this specific FDA letter is a regulatory clearance document, not a detailed study report.

Therefore, I cannot provide the requested information from the given input.

Ask a specific question about this device

The Amylase Reagent is to be used in the assessment of pancreatitis.

Not Found

The provided text is related to a 510(k) clearance letter for an Amylase Reagent, an in vitro diagnostic device used for the assessment of pancreatitis. This type of document, particularly a 510(k) summary (which is not fully provided here but implied by the clearance letter), typically focuses on demonstrating substantial equivalence to a predicate device rather than providing a detailed study description with acceptance criteria and device performance results as would be found in a clinical study report or a more comprehensive premarket approval (PMA) application.

Therefore, the requested information elements related to detailed study design, sample sizes, ground truth establishment, expert qualifications, and specific performance metrics are not available in the provided document. The document states "we have determined the device is substantially equivalent...to devices marketed in interstate commerce prior to May 28, 1976." This implies that the device's performance was compared to a legally marketed predicate device, and the specifics of that comparison, including the criteria and results, would be in the full 510(k) submission, not typically summarized in the clearance letter itself.

Given this, I cannot fill out the requested table and answer the specific questions about acceptance criteria and study details.

Ask a specific question about this device